Removing one ovary does not necessarily eliminate ovarian hormone production, whereas removing both ends production from the ovaries and causes surgical menopause. This distinction affects clinical planning because bilateral surgery requires attention to menopausal symptoms, fertility implications, and longer-term health effects. The number of ovaries removed therefore influences counseling, risk assessment, and follow-up needs.
The ovary is connected to supporting tissues and a blood supply that must be separated during surgery. Careful control of these connections helps manage bleeding while allowing the surgical specimen to be removed. This anatomical step is central to safe operative technique and applies whether surgeons reach the pelvis through laparoscopic access or an open approach.
Ovaries excision can be performed through laparoscopic or open surgery, representing different ways to access the pelvis. The selected approach forms part of the operative plan and must accommodate the condition being treated, the intended specimen removal, and control of bleeding. The source material identifies both approaches but does not specify a universal choice for every patient.
Clinical indications include ovarian cancer, persistent cysts, endometriosis, and ovarian torsion. These conditions differ in their medical context, but each can prompt consideration of surgical removal when treatment requires addressing the affected ovary. Inherited susceptibility to cancer represents another context, where surgery may be considered primarily to reduce a specific future health risk.
The procedure begins with pelvic access, using either laparoscopic or open surgery. The surgeon then separates the ovary from its supporting tissues and blood supply, controls bleeding, and removes the surgical specimen. These steps describe the essential operative sequence without determining whether one or both ovaries are removed, since that decision depends on the clinical indication and plan.
Assessment before removal of both ovaries is important because bilateral surgery ends ovarian hormone production and causes surgical menopause. Planning should therefore address fertility as well as expected symptoms and longer-term health effects. These considerations help clinicians and patients weigh the intended treatment or risk reduction against consequences that follow from loss of ovarian function.
For people with an inherited susceptibility to cancer, removing the ovaries may lower a specific cancer risk rather than treat an already diagnosed tumor. This preventive context differs from surgery for ovarian cancer, persistent cysts, endometriosis, or torsion. The decision still requires clinical planning because bilateral removal ends ovarian hormone production and causes surgical menopause.